Allogeneic B7H3 CAR-γδT Cell Therapy

B7H3 CAR-γδT cell therapy · Peking University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic B7H3 CAR-γδT Cell Therapy, covering 2025-02-13 to 2025-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors [EARLY_Phase 1]